Key Takeaways
- • A federal judge partially survived a 3M ERISA lawsuit by dismissing claims against Fidelity target-date funds while allowing remaining breach-of-fiduciary-duty claims to proceed against 3M's customized target-date funds.
- • The court ruled that Fidelity funds qualified as a "meaningful benchmark" for evaluating 3M's proprietary target-date fund performance, establishing a critical evidentiary standard for ERISA prudence challenges in 401(k) plan litigation.
- • 3M employees alleged the company violated ERISA's duty of prudence by continuing to offer underperforming customized target-date funds despite availability of superior alternatives (including S&P Target Date Indices and competitor funds from Fidelity and other providers).
- • The ruling clarifies that plaintiffs must allege specific facts showing fiduciary imprudence rather than relying on general performance comparisons, raising the threshold for surviving motions to dismiss in target-date fund cases.
- • This case establishes precedent for how courts evaluate benchmark appropriateness in ERISA litigation, with implications for plan sponsors offering proprietary or customized investment options alongside industry-standard alternatives.
Summary
A federal judge has issued a mixed ruling in an ERISA lawsuit against 3M Co., dismissing certain claims while allowing the core fiduciary breach allegations to proceed. The decision represents a nuanced application of ERISA prudence standards in evaluating the appropriateness of proprietary target-date funds offered in corporate 401(k) plans.
The plaintiffs—3M employees participating in the company's 401(k) plan—alleged that 3M violated its fiduciary duties under ERISA by continuing to offer customized target-date funds that underperformed relative to available alternatives. The court dismissed claims challenging Fidelity's target-date funds included in the plan, finding they qualified as a "meaningful benchmark" for evaluating performance. However, the judge allowed claims against 3M's own customized target-date funds to survive the initial pleading stage.
The employees benchmarked the 3M funds' performance against the S&P Target Date Indices and target-date offerings from Fidelity and other major providers. The court's finding that Fidelity funds satisfied benchmark requirements suggests the judge accepted that commercially available, well-established target-date fund families provide sufficient comparative data for assessing prudence. This distinction appears critical: while Fidelity faced dismissal, 3M's proprietary offerings did not, implying the court found plausible allegations that 3M's custom funds underperformed meaningful comparators.
The ruling establishes important precedent for ERISA litigation by clarifying that plaintiffs must allege specific facts demonstrating fiduciary imprudence—not merely general performance shortfalls. The standard requires showing that prudent fiduciaries would have known about superior alternatives and should have removed underperforming options. For plan sponsors and institutional investors, the decision underscores the growing scrutiny of proprietary investment options and the evidentiary burden courts now impose when challenging 401(k) plan fund lineups. The case also reflects broader institutional pressure to justify custom investment solutions when industry-standard alternatives demonstrate comparable or superior risk-adjusted returns.
The plaintiffs—3M employees participating in the company's 401(k) plan—alleged that 3M violated its fiduciary duties under ERISA by continuing to offer customized target-date funds that underperformed relative to available alternatives. The court dismissed claims challenging Fidelity's target-date funds included in the plan, finding they qualified as a "meaningful benchmark" for evaluating performance. However, the judge allowed claims against 3M's own customized target-date funds to survive the initial pleading stage.
The employees benchmarked the 3M funds' performance against the S&P Target Date Indices and target-date offerings from Fidelity and other major providers. The court's finding that Fidelity funds satisfied benchmark requirements suggests the judge accepted that commercially available, well-established target-date fund families provide sufficient comparative data for assessing prudence. This distinction appears critical: while Fidelity faced dismissal, 3M's proprietary offerings did not, implying the court found plausible allegations that 3M's custom funds underperformed meaningful comparators.
The ruling establishes important precedent for ERISA litigation by clarifying that plaintiffs must allege specific facts demonstrating fiduciary imprudence—not merely general performance shortfalls. The standard requires showing that prudent fiduciaries would have known about superior alternatives and should have removed underperforming options. For plan sponsors and institutional investors, the decision underscores the growing scrutiny of proprietary investment options and the evidentiary burden courts now impose when challenging 401(k) plan fund lineups. The case also reflects broader institutional pressure to justify custom investment solutions when industry-standard alternatives demonstrate comparable or superior risk-adjusted returns.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.